BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22532827)

  • 1. Phosphofructo-2-kinase/fructose-2,6-bisphosphatase modulates oscillations of pancreatic islet metabolism.
    Merrins MJ; Bertram R; Sherman A; Satin LS
    PLoS One; 2012; 7(4):e34036. PubMed ID: 22532827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells.
    Arden C; Hampson LJ; Huang GC; Shaw JA; Aldibbiat A; Holliman G; Manas D; Khan S; Lange AJ; Agius L
    Biochem J; 2008 Apr; 411(1):41-51. PubMed ID: 18039179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycolysis in hepatocytes from Zucker fa/fa rats.
    Payne VA; Arden C; Lange AJ; Agius L
    Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R618-25. PubMed ID: 17553851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells.
    Massa L; Baltrusch S; Okar DA; Lange AJ; Lenzen S; Tiedge M
    Diabetes; 2004 Apr; 53(4):1020-9. PubMed ID: 15047617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein.
    Cullen KS; Al-Oanzi ZH; O'Harte FP; Agius L; Arden C
    Biochim Biophys Acta; 2014 Jun; 1843(6):1123-34. PubMed ID: 24566088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct measurements of oscillatory glycolysis in pancreatic islet β-cells using novel fluorescence resonance energy transfer (FRET) biosensors for pyruvate kinase M2 activity.
    Merrins MJ; Van Dyke AR; Mapp AK; Rizzo MA; Satin LS
    J Biol Chem; 2013 Nov; 288(46):33312-22. PubMed ID: 24100037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved metabolic stimulus for glucose-induced insulin secretion through GK and PFK-2/FBPase-2 coexpression in insulin-producing RINm5F cells.
    Baltrusch S; Langer S; Massa L; Tiedge M; Lenzen S
    Endocrinology; 2006 Dec; 147(12):5768-76. PubMed ID: 16980436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow oscillations persist in pancreatic beta cells lacking phosphofructokinase M.
    Marinelli I; Parekh V; Fletcher P; Thompson B; Ren J; Tang X; Saunders TL; Ha J; Sherman A; Bertram R; Satin LS
    Biophys J; 2022 Mar; 121(5):692-704. PubMed ID: 35131294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells.
    Cullen KS; Matschinsky FM; Agius L; Arden C
    Diabetes; 2011 Dec; 60(12):3175-85. PubMed ID: 22028181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous activation of glucokinase by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is glucose dependent.
    Langer S; Kaminski MT; Lenzen S; Baltrusch S
    Mol Endocrinol; 2010 Oct; 24(10):1988-97. PubMed ID: 20702580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner.
    Baltrusch S; Lenzen S; Okar DA; Lange AJ; Tiedge M
    J Biol Chem; 2001 Nov; 276(47):43915-23. PubMed ID: 11522786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular coordination of hepatic glucose metabolism by the 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase:glucokinase complex.
    Smith WE; Langer S; Wu C; Baltrusch S; Okar DA
    Mol Endocrinol; 2007 Jun; 21(6):1478-87. PubMed ID: 17374851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes.
    Payne VA; Arden C; Wu C; Lange AJ; Agius L
    Diabetes; 2005 Jul; 54(7):1949-57. PubMed ID: 15983194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing Glucokinase Activity Restores Endogenous Pulsatility and Enhances Insulin Secretion in Islets From db/db Mice.
    Jahan I; Corbin KL; Bogart AM; Whitticar NB; Waters CD; Schildmeyer C; Vann NW; West HL; Law NC; Wiseman JS; Nunemaker CS
    Endocrinology; 2018 Nov; 159(11):3747-3760. PubMed ID: 30239634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive activation of glucokinase by the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and the chemical activator LY2121260.
    Baltrusch S; Schmitt H; Brix A; Langer S; Lenzen S
    Biochem Pharmacol; 2012 May; 83(9):1300-6. PubMed ID: 22305745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor α is involved in the transcriptional regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene.
    Zhao LF; Iwasaki Y; Nishiyama M; Taguchi T; Tsugita M; Okazaki M; Nakayama S; Kambayashi M; Fujimoto S; Hashimoto K; Murao K; Terada Y
    Diabetes; 2012 May; 61(5):1062-71. PubMed ID: 22415873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Mukhtar MH; Payne VA; Arden C; Harbottle A; Khan S; Lange AJ; Agius L
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R766-74. PubMed ID: 18199594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intact pancreatic islets and dispersed beta-cells both generate intracellular calcium oscillations but differ in their responsiveness to glucose.
    Scarl RT; Corbin KL; Vann NW; Smith HM; Satin LS; Sherman A; Nunemaker CS
    Cell Calcium; 2019 Nov; 83():102081. PubMed ID: 31563790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1α/PFKFB3/PFK1 pathway.
    Hu L; Zeng Z; Xia Q; Liu Z; Feng X; Chen J; Huang M; Chen L; Fang Z; Liu Q; Zeng H; Zhou X; Liu J
    Life Sci; 2019 Dec; 239():116966. PubMed ID: 31626790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and small chemical activators affect enzyme activity of activating glucokinase mutants by distinct mechanisms.
    Langer S; Hofmeister-Brix A; Waterstradt R; Baltrusch S
    Biochem Pharmacol; 2019 Oct; 168():149-161. PubMed ID: 31254492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.